Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis

Hepatology Research

Volumn 32, Issue 2, 2005, Pages 127-133

  Cheong, Jae Youn ^a   Lee, Kee Myung ^a   Cho, Sung Won ^a   Won, Je Hwan ^a   Kim, Jai Keun ^a   Wang, Hee Jung ^a   Hahm, Ki Baik ^a   Kim, Jin Hong ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Arterial infusion chemotherapy; Hepatocellular carcinoma; Portal vein; Tumor thrombosis

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C;

ABDOMINAL PAIN; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INFECTION; LIVER CELL CARCINOMA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC THERAPY; TREATMENT OUTCOME;

EID: 21744455320     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.01.015     Document Type: Article

References (27)

1. K. Okuda T. Ohtsuki H. Obata et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 1985 918-928
2. J. Bruix I. Cirera X. Calvet et al. Surgical resection and survival in Western patients with hepatocellular carcinoma J Hepatol 15 1992 350-355
3. H. Bismuth D. Houssin J. Ornowski F. Meriggi Liver resections in cirrhotic patients: A western experience World J Surg 10 1986 311-317
4. C.L. Liu S.T. Fan Nonresectional therapies for hepatocellular carcinoma Am J Surg 173 1997 358-365
5. T. Lehnert C. Herfarth Chemoembolization for hepatocellular carcinoma. What, when, and for whom? Ann Surg 224 1996 1-3
6. J. Bruix J.M. Llovet A. Castells et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578-1583
7. G. Pelletier M. Ducreux F. Gay et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Group CHC J Hepatol 29 1998 129-134
8. B. Carr Diagnosis and treatment of hepatocellular carcinoma 1997 Greenwich Medical Media Inc. London
9. E.E. Tzoracoleftherakis J.D. Spiliotis T. Kyriakopoulou S.K. Kakkos Intra-arterial versus systemic chemotherapy for non-operable hepatocellular carcinoma Hepatogastroenterology 46 1999 1122-1125
10. S. Katyal J.H. Oliver M.S. Peterson P.J. Chang R.L. Baron B.I. Carr Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: A retrospective analysis AJR Am J Roentgenol 175 2000 1665-1672
11. H. Nakamura T. Hashimoto H. Oi S. Sawada Transcatheter oily chemoembolization of hepatocellular carcinoma Radiology 170 1989 783-786
12. M. Kajanti P. Rissanen P. Virkkunen K. Franssila M. Mantyla Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma. A phase II study Cancer 58 1986 2386-2388
13. M. Yasui T. Nonami T. Kurokawa et al. Effects of hepatic arterial infusion chemotherapy on unresectable or recurrent hepatocellular carcinoma Cancer Chemother Pharmacol 33 Suppl. 1994 S139-S141
14. H. Eggel Uber das primare Karcinom der Leber Beitr Pathol Anat Allg Pathol 30 1901 139-141
15. A.B. Miller B. Hoogstraten M. Staquet A. Winkler Reporting results of cancer treatment Cancer 47 1981 207-214
16. Y.C. Lai C.Y. Shih C.M. Jeng et al. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis World J Gastroenterol 9 2003 2666-2670
17. E. Ando F. Yamashita M. Tanaka K. Tanikawa A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein Cancer 79 1997 1890-1896
18. C. Kalayci P.J. Johnson N. Raby E.M. Metivier R. Williams Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: A comparison with intravenous adriamycin J Hepatol 11 1990 349-353
19. T. Iwamiya S. Sawada Y. Ohta Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system Cancer Chemother Pharmacol 33 Suppl. 1994 S134-S138
20. Y.H. Chung I.H. Song B.C. Song et al. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis Cancer 88 2000 1986-1991
21. C.L. Lai P.C. Wu G.C. Chan A.S. Lok H.J. Lin Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial Cancer 62 1988 479-483
22. G. Falkson L.M. Ryan L.A. Johnson et al. A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study Cancer 60 1987 2141-2145
23. S.R. Nerenstone D.C. Ihde M.A. Friedman Clinical trials in primary hepatocellular carcinoma: Current status and future directions Cancer Treat Rev 15 1988 1-31
24. H. Tanioka A. Tsuji S. Morita et al. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma Anticancer Res 23 2003 1891-1897
25. H. Yodono Y. Saito Y. Saikawa H. Midorikawa Y. Yokoyama S. Takekawa Combination chemoembolization therapy for hepatocellular carcinoma: mainly, using cisplatin (CDDP) Cancer Chemother Pharmacol 23 Suppl. 1989 S42-S44
26. T. Shirasaka Y. Shimamoto H. Ohshimo H. Saito M. Fukushima Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo Cancer Chemother Pharmacol 32 1993 167-172
27. Y. Yamashita M. Takahashi Y. Koga et al. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion Cancer 67 1991 385-391